Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends

BACKGROUND Endometrial cancer is the fifteenth most common malignant disease in the world. It is estimated that 417,367 new cases of this malignant neoplasm are diagnosed annually and 97,370 women die from it. OBJECTIVE The epidemiological features of the corpus uteri cancer (CUC) incidence and its spatial and temporal assessment in Kazakhstan were studied. METHODS The retrospective study was done for the period 2009-2018. Descriptive and analytical methods of epidemiology were used. Crude, age-specific, age-standardized, equalized incidence rates and approximation were calculated. The method of drawing up a cartogram based on the determination of the standard deviation (σ) from the mean (x) was applied. RESULT During the study period, 10,522 new cases of CUC were registered. The average annual age-standardized incidence rate was 11.1±0.2 cases per 100,000 population of female, (Т=+0.6%; R2=0.083). The analysis of ASIR showed unimodal growth with a peak at 65-69 years - 58.8±3.6 cases per 100,000 population of female. The most pronounced downward trend was revealed in the age group < 30 years (T=-2.6%), and the most pronounced annual average upward rates was in 80-84 years (T=+6.4%). The results of the spatial analysis showed regions with a higher levels of CUC incidence rate per 100,000 population of female: Pavlodar, Kostanay, Karaganda, Almaty city, North Kazakhstan and Astana city. CONCLUSION In recent years, CUC incidence in Kazakhstan has been increasing. High incidence rates were found in the northern regions of the country, and the trend of incidence growth was more pronounced in the western and eastern regions.

[1]  S. Urazova,et al.  Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis , 2021, Asian Pacific journal of cancer prevention : APJCP.

[2]  S. Urazova,et al.  New Trends of Cervical Cancer Incidence in Kazakhstan , 2021, Asian Pacific journal of cancer prevention : APJCP.

[3]  A. Satanova,et al.  78 Evaluation changes in indicators of oncological service in cervix uteri cancer in Kazakhstan , 2020 .

[4]  Z. Khazaei,et al.  Association between the incidence and mortality rates for corpus uteri cancer and human development index (HDI): a global ecological study , 2020, Obstetrics & gynecology science.

[5]  H. Baradaran,et al.  The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis , 2019, BMC Cancer.

[6]  H. Gabra,et al.  Risk factors for endometrial cancer: An umbrella review of the literature , 2019, International journal of cancer.

[7]  A. K. Eshmanova,et al.  Aging of the Population in Kazakhstan. 1. Problems and Opportunities , 2018, Advances in Gerontology.

[8]  Jacques Ferlay,et al.  International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013. , 2018, Journal of the National Cancer Institute.

[9]  C. Kawas,et al.  Cancer—Incidence, prevalence and mortality in the oldest-old. A comprehensive review , 2017, Mechanisms of Ageing and Development.

[10]  A. Kataki,et al.  Epidemiology of gynecological cancers in Kamrup Urban District cancer registry. , 2017, Indian journal of cancer.

[11]  A. Ludwin,et al.  Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socioeconomic changes , 2016, OncoTargets and therapy.

[12]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[13]  N. Igissinov,et al.  Estimation of the Change of Ovarian Cancer Incidence in Kazakhstan: Component Analysis of Its Dynamics with the Consideration of Ethnic Features , 2016, Iranian journal of public health.

[14]  M. Saidani,et al.  Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  Ole Mogensen,et al.  Trends in gynecologic cancer among elderly women in Denmark, 1980–2012 , 2016, Acta oncologica.

[16]  Richard Stevens,et al.  Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. , 2015, The Lancet. Oncology.

[17]  L. Brinton,et al.  Menopausal hormone therapy and risk of endometrial cancer , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  John A. Barry,et al.  Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2014, Human reproduction update.

[19]  M. Sherman,et al.  Recent changes in endometrial cancer trends among menopausal-age U.S. women. , 2013, Cancer epidemiology.

[20]  M. E. El behery,et al.  Diagnostic accuracy of uterine fluid lactate dehydrogenase isoenzyme activity profile and vaginal ultrasound in detecting endometrial cancer in women with postmenopausal bleeding , 2010, Archives of Gynecology and Obstetrics.

[21]  R. Strickler,et al.  Menopausal hormone therapy. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[22]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[23]  Rafael Lozano,et al.  AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .

[24]  C. Bankhead,et al.  [Cancer of the corpus uteri]. , 1979, Fel'dsher i akusherka.

[25]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.